GRHPR Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1A9]

CAT#: TA502086BM

GRHPR mouse monoclonal antibody, clone OTI1A9 (formerly 1A9), HRP conjugated

Conjugation: Unconjugated Biotin HRP



  View other "OTI1A9" antibodies (4)

Need it in bulk or conjugated?
Get a free quote

CNY 3,990.00


货期*
2周

规格
    • 100 ul

经常一起买 (3)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Recombinant protein of human glyoxylate reductase/hydroxypyruvate reductase (GRHPR), 20 µg
    • 20 ug

CNY 2,900.00
CNY 6,650.00


Transient overexpression lysate of glyoxylate reductase/hydroxypyruvate reductase (GRHPR)
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Clone Name OTI1A9
Applications FC, IHC, WB
Recommend Dilution WB 1:500~2000, IHC 1:150, FLOW 1:100
Reactivity Human, Mouse, Rat
Host Mouse
Clonality Monoclonal
Immunogen Full length human recombinant protein of human GRHPR (NP_036335) produced in HEK293T cell.
Formulation PBS (pH 7.3) containing 1% BSA, 50% glycerol.
Concentration 0.5 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation HRP
Storage Condition Store at -20°C as received.
Predicted Protein Size 35.5 kDa
Gene Name glyoxylate and hydroxypyruvate reductase
Background This gene encodes an enzyme with hydroxypyruvate reductase, glyoxylate reductase, and D-glycerate dehydrogenase enzymatic activities. The enzyme has widespread tissue expression and has a role in metabolism. Type II hyperoxaluria is caused by mutations in this gene. [provided by RefSeq]
Synonyms GLXR; GLYD; PH2
Reference Data
Protein Families Druggable Genome
Protein Pathways Glyoxylate and dicarboxylate metabolism, Metabolic pathways, Pyruvate metabolism
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...